MedTrace Logo

Memory Functions in Mild Alzheimer's Disease

NCT04785053 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2024-06-26

No results posted yet for this study

Summary

The overall objective of this project is to examine the effects of non-invasive brain stimulation on episodic memory performance

Conditions

  • Alzheimer Disease

Interventions

DEVICE

transcranial alternating current stimulation (tACS)

The tACS intervention (gamma stimulation, theta stimulation and active sham condition) will be administered to the participants over three visits that will be completed within one of the working days (Mon-Fri) at approximately the same time of day for all participants. Participants will be randomized and blinded to the tACS treatment.

Sponsors & Collaborators

  • Hebrew SeniorLife

    lead OTHER

Principal Investigators

  • Alvaro Pascual-Leone, Dr. · Hinda and Arthur Marcus Institute for Aging Research

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-06-22
Primary Completion
2023-09-30
Completion
2023-09-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04785053 on ClinicalTrials.gov